Even though human skin has a remarkable ability to heal after injury, this natural healing mechanism occasionally fails, resulting in a chronic wound. Such chronic wounds contribute to enormous costs for the European healthcare system and heavily diminish the quality of life of affected individuals. Improved strategies to tackle this problem are urgently needed. Here, SPEEDER technology can step in as a preventive or corrective measure. By using electrical stimulation to drive the migration of skin cells, the epithelial cell layer can cover the wound area faster, reducing the time window for infection to occur. Thus, while regular wound care focuses on mechanically protecting and supporting the wound during closure while leaving the rest up to the natural regenerative process, SPEEDER is meant to actively “fast forward” the natural healing process and restore the epithelium’s protectoral barrier.
The working hypothesis of SPEEDER has been that electrical fields (EFs), applied over an open wound, act as a guidance signal for skin cells involved in re-epithelialization. In other words, we exploit skin cells’ “electrotactic” ability to manipulate and force them to move faster into the wound area. The idea of such a concept is not original to SPEEDER and has, in fact, been explored in numerous studies but with inconsistent outcomes. A key component has been missing for successfully exploiting electrotaxis, mainly an electrode material capable of sustaining direct current (DC) stimulation over long periods without dissolving the stimulating electrodes and damaging surrounding tissue. SPEEDER has managed to close this gap by working in parallel on biological models, materials science, and electrochemistry.
The unique idea we have followed is to use the super-capacitive properties of polymer electrodes, mainly the conducting polymer poly(3-4-ethylene dioxythiophene (PEDOT), to make DC stimulation of tissue possible. While metal electrodes corrode under DC, a conducting polymer layer makes it possible to move ions in solution through a reversible process.
In SPEEDER, we have deep-dived into the fundamentals of skin cell electrotaxis and, in parallel, studied how the electrode material plays a crucial role in enabling such stimulation in a biocompatible manner. We have developed novel electrode material compositions, which led us to step away from metals and instead introduce combinations of laser-induced graphene (LIG) and conducting polymers to make cheap, scalable, and sustainable versions of the technology possible. We have demonstrated our concept on healthy epithelial cell layers, as well as cell layers modified to mimic impaired wound healing in diabetes. Finally, we propose how this concept can best be shaped using methods and materials that would allow scaling to large-area wound dressings that could be sufficiently cheap to be used as consumables in medical care.